Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

78%

7 of 9 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

N/A

7(77.8%)

Phase 1

2(22.2%)

9Total

N/A(7)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05980013Not ApplicableCompleted

Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the CM-1500

Role: lead

NCT05012462Not ApplicableCompleted

Clinical Evaluation of the CM-1500 During Apheresis Blood Donation

Role: lead

NCT05463198Not ApplicableCompleted

Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600

Role: lead

NCT05740644Not ApplicableCompleted

Clinical Evaluation of the Zynex Monitoring System, Model CM-1600

Role: lead

NCT05125848Not ApplicableCompleted

Clinical Evaluation of the CM-1500 During Hemodialysis

Role: lead

NCT04706221Not ApplicableCompleted

Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients

Role: lead

NCT01846195Not ApplicableCompleted

Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw

Role: lead

NCT01834612Phase 1Completed

Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw

Role: lead

NCT01646060Phase 1Completed

Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw

Role: lead

All 9 trials loaded